Prolonged Oral Etoposide in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

This publication has 11 references indexed in Scilit:

• Clinical Trial of Daily Low‐Dose Oral Etoposide for Patients with Residual or Recurrent Cancer of the Ovary or Uterus
  Journal of Obstetrics and Gynaecology, 1995
• Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
  Journal of Clinical Oncology, 1995
• Phase I Study and Clinical Pharmacological Evaluation of Daily Oral Etoposide Combined with Carboplatin in Patients with Lung Cancer
  Japanese Journal of Cancer Research, 1995
• Inefficacy of Low-Dose Continuous Oral Etoposide in Non-Small Cell Lung Cancer
  American Journal of Clinical Oncology, 1994
• Chronic oral etoposide in non-small cell lung carcinoma
  European Journal Of Cancer, 1992
• Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.
  Journal of Clinical Oncology, 1992
• Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• Clinical Pharmacology and Toxicity of Low Daily Administration of Oral Etoposide in Advanced Lung Cancer Patients
  The Journal of Clinical Pharmacology, 1991
• A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer
  Cancer, 1991
• SCHEDULE DEPENDENCY OF THE ANTILEUKEMIC ACTIVITY OF THE PODOPHYLLOTOXIN‐DERIVATIVE VP 16–213 (NSC‐141540) IN L1210 LEUKEMIA
  Acta Pathologica Microbiologica Scandinavica Section A Pathology, 1973